Back to
LAZARD ASSET MANAGEMENT LLC
SRNE
Showing 0 of 8 quarters
Position history for
LAZARD ASSET MANAGEMENT LLC's holdings in SORRENTO THERAPEUTICS INC
As of its Q4 2022 13F, Lazard Asset Management held 40,229 shares of SRNE (Sorrento Therapeutics), worth $35,000.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.